Onco-nephrology

Section 1. Fluid and electrolyte disorders in cancer patients.
Kidney function.
Dysnatremias in cancer.
Potassium disorders.
Calcium and phosphorus disorders.
Volume disorders and fluid resuscitation.
Section 2. Paraprotein-related kidney diseases.
Paraproteins.
Cast nephropathy.
Systemic light chain amyloidosis.
Monoclonal immunoglobulin deposition disease.
Fibrillary and immunotactoid glomerulonephritis.
Section 3. Hematopoietic stem cell associated kidney disease.
Hematopoietic cell transplant associated kidney injury.
Sinusoidal obstruction syndrome.
Thrombotic microangiopathy.
Graft-versus-host disease.
Chronic kidney disease, end-stage renal disease, and bone marrow transplant.
Section 4. Chemotherapy and radiation related kidney diseases.
Conventional chemotherapy.
Targeted cancer therapies (biologics).
Adverse kidney effects of immunotherapies.
Chemotherapy in chronic kidney disease and dialysis.
Radiation nephropathy.
Section 5. Paraneoplastic glomerulopathies.
Paraneoplastic glomerular diseases.
Paraneoplastic glomerulonephritis.
Hematologic malignancies.
Cancer screening recommendations.
Section 6. Renal tumors.
Renal cell cancer.
Wilms tumor and Von Hippel Lindau disease.
Tuberous sclerosis complex and the kidney.
Evaluation of a renal cyst/mass.
Section 7. Acute kidney injury.
Acute kidney injury incidence, pathogenesis, and outcomes.
Tumor lysis syndrome.
Obstructive nephropathy in cancer.
Renal replacement therapies.
Section 8. Chronic kidney disease and cancer.
Chronic kidney disease as a complication of cancer, with special focus on kidney and urothelial tumors.
Incidence of cancer and screening recommendations.
Cancer in renal transplant patients.
Section 9. Kidney infections.
Renal infections in cancer patients.
Section 10. Infiltrative diseases.
Kidney disease in leukemia.
Kidney disease in lymphoma